Your session is about to expire
← Back to Search
Weighted Blankets for Recovery from Heart Procedures
N/A
Recruiting
Led By Brian Armstrong, RN
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 minutes (after arrived to pacu)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if using a heavy blanket can help calm patients after heart procedures. The goal is to see if the blanket can reduce their agitation, so they need less extra medicine and have fewer complications.
Who is the study for?
This trial is for pediatric cardiology patients weighing between 40 and 220 pounds who are recovering from cardiac catheterization or electrophysiology procedures. They must plan to recover in the cardiac PACU for over 2 hours. It's not for those with severe asthma, recent open heart surgery, certain muscular disorders, skin issues, severe pulmonary hypertension, PTSD, claustrophobia, uncontrolled seizures, specific lung diseases or those needing immediate post-procedure tests.
What is being tested?
The study is testing if using a weighted blanket after heart-related procedures can calm patients more effectively than usual care without blankets. The goal is to see if this leads to less need for extra sedation and fewer complications related to blood vessels after the procedure.
What are the potential side effects?
Potential side effects may include discomfort due to weight of the blanket leading possibly to increased anxiety or difficulty breathing especially in patients with underlying respiratory issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 60 minutes (after arrived to pacu)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 minutes (after arrived to pacu)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average Richmond Agitation Sedation Scale (RASS) compared between the two groups
Secondary study objectives
Analgesia administered in the recovery area
Incidence of vascular complications in the recovery area
Safety measures assessed by vital sign parameters for absolute oxygen (O2 saturation)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Weighted blanketExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Weighted blanket
2018
N/A
~30
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for cardiac catheterization include sedation and analgesia to manage pain and anxiety, as well as anticoagulants to prevent thrombosis. Sedation and analgesia work by depressing the central nervous system to reduce anxiety and pain, which is crucial for patient comfort and cooperation during the procedure.
Anticoagulants prevent blood clot formation, reducing the risk of complications such as stroke or myocardial infarction. The use of weighted blankets, which provide deep pressure stimulation, can reduce agitation and anxiety, potentially decreasing the need for additional sedation and improving overall patient outcomes.
A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock.Management of cardiogenic shock.Transcatheter Intervention of Coronary Obstructions in Infants, Children, and Young Adults.
A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock.Management of cardiogenic shock.Transcatheter Intervention of Coronary Obstructions in Infants, Children, and Young Adults.
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,853 Previous Clinical Trials
6,432,905 Total Patients Enrolled
Brian Armstrong, RNPrincipal InvestigatorUniversity of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I weigh less than 40 pounds.I weigh more than 220 pounds.I need heart and lung checks right after surgery.I have not had open heart surgery in the last 30 days.I have severe asthma.I have a tracheostomy.I am currently using a cast, brace, or splint due to fractures.I have severe high blood pressure in the lungs.I will be on bed rest for more than 2 hours after my procedure.I have seizures that are not controlled by medication.I have been diagnosed with PTSD.I have a lung condition that restricts my breathing, like scoliosis.I have areas of damaged skin.I am undergoing a heart procedure involving catheters.I have a feeding tube placed through my abdomen.I have a condition like cerebral palsy that affects my muscles.I have been diagnosed with diaphragm weakness.
Research Study Groups:
This trial has the following groups:- Group 1: Weighted blanket
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger